Benjamin Pelletier News Today

With epitope claims less available post-Amgen v. Sanofi, this article examines four useful approaches that you and your antibody patent lawyer can...

Making Sense Of Antibody Epitope Claims By Benjamin Pelletier, Haynes and Boone The antibody therapeutics industry has mushroomed into a sector whose value is estimated to reach $138.6 billion by 2024. 1 And this astounding economic growth has been accompanied by equally astonishing technological advancement. Obtaining certain types of patent rights to antibodies has become increasingly challenging in the United States. 2 To comprehend this evolution, we must first take a careful look at what a...